Christopher G. V. Sharples

786 total citations
12 papers, 665 citations indexed

About

Christopher G. V. Sharples is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher G. V. Sharples has authored 12 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher G. V. Sharples's work include Nicotinic Acetylcholine Receptors Study (12 papers), Receptor Mechanisms and Signaling (6 papers) and Synthesis and Biological Evaluation (4 papers). Christopher G. V. Sharples is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (12 papers), Receptor Mechanisms and Signaling (6 papers) and Synthesis and Biological Evaluation (4 papers). Christopher G. V. Sharples collaborates with scholars based in United Kingdom, Australia and United States. Christopher G. V. Sharples's co-authors include Susan Wonnacott, Paul Whiteaker, Timothy Gallagher, Britta Hahn, Mohammed Shoaib, Ian P. Stolerman, William S. Caldwell, Jeffrey D. Schmitt, James A. Spencer and L. Soliakov and has published in prestigious journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Christopher G. V. Sharples

12 papers receiving 648 citations

Peers

Countries citing papers authored by Christopher G. V. Sharples

Since Specialization

Citations

This map shows the geographic impact of Christopher G. V. Sharples's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. V. Sharples with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. V. Sharples more than expected).

Fields of papers citing papers by Christopher G. V. Sharples

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. V. Sharples. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. V. Sharples. The network helps show where Christopher G. V. Sharples may publish in the future.

Co-authorship network of co-authors of Christopher G. V. Sharples

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. V. Sharples. A scholar is included among the top collaborators of Christopher G. V. Sharples based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. V. Sharples. Christopher G. V. Sharples is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380 2004 ·Neuropharmacology ·Adrian J. Mogg, (unknown), Ian A. Pullar, Christopher G. V. Sharples, Susan Wonnacott	30
2	Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with α7 selectivity 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jonathan M. Large, Christopher G. V. Sharples, Andrew Sutherland, Timothy Gallagher, Susan Wonnacott	17
3	Attentional effects of nicotinic agonists in rats 2003 ·Neuropharmacology ·Britta Hahn, Christopher G. V. Sharples, Susan Wonnacott, Mohammed Shoaib, Ian P. Stolerman	111
4	Synthesis of Two Fluoro Analogues of the Nicotinic Acetylcholine Receptor Agonist UB-165 2003 ·The Journal of Organic Chemistry ·Andrew Sutherland, Timothy Gallagher, Christopher G. V. Sharples, Susan Wonnacott	20
5	Synthesis and Pharmacological Characterization of Novel Analogues of the Nicotinic Acetylcholine Receptor Agonist (±)-UB-165 2002 ·Journal of Medicinal Chemistry ·Christopher G. V. Sharples, (unknown), Graham L. Simpson, James A. Spencer, (unknown), Neil S. Millar, Susan Wonnacott, Timothy Gallagher	38
6	Characterisation of UB-165 analogues at the alpha3beta4 nicotinic acetylcholine receptor 2001 ·The Society for Neuroscience Abstracts ·Christopher G. V. Sharples, Ian W. Jones, Neil S. Millar, (unknown), Timothy Gallagher, Susan Wonnacott	1
7	Neuronal nicotinic receptors 2001 ·Asian Journal of Neurosurgery ·Christopher G. V. Sharples, Susan Wonnacott	119
8	UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes 2000 ·Journal of Neuroscience ·Christopher G. V. Sharples, Sergio Kaiser, L. Soliakov, (unknown), Allan C. Collins, Mark Washburn, (unknown), James A. Spencer, (unknown), Paul Whiteaker, Susan Wonnacott	144
9	Molecular Recognition in Nicotinic Acetylcholine Receptors: The Importance of π−Cation Interactions 1999 ·Journal of Medicinal Chemistry ·Jeffrey D. Schmitt, Christopher G. V. Sharples, William S. Caldwell	64
10	Agonist-Induced Up-Regulation of α4β2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition 1998 ·Molecular Pharmacology ·Paul Whiteaker, Christopher G. V. Sharples, Susan Wonnacott	70
11	Synthesis of UB-165: A novel nicotinic ligand and anatoxin-a/epibatidine hybrid 1997 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Timothy Gallagher, Christopher G. V. Sharples, Susan Wonnacott	49
12	Pharmacology of nicotinic acetylcholine receptor (nAChR) upregulation in the transfected cell line, M10 1997 ·Biochemical Society Transactions ·Paul Whiteaker, Christopher G. V. Sharples, Susan Wonnacott	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact